tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

REGN Stock Latest News

Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
Press ReleasesRegeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
6h ago
REGN
SVB Securities upgrades Regeneron to Outperform, sees positive drivers ahead
The FlySVB Securities upgrades Regeneron to Outperform, sees positive drivers ahead
1d ago
REGN
Regeneron upgraded to Outperform from Market Perform at SVB Securities
The FlyRegeneron upgraded to Outperform from Market Perform at SVB Securities
1d ago
REGN
Regeneron May Win Big with New Drug
Market NewsRegeneron May Win Big with New Drug
4d ago
REGN
Regeneron price target raised to $1,040 from $1,025 at BMO Capital
The FlyRegeneron price target raised to $1,040 from $1,025 at BMO Capital
4d ago
REGN
Regeneron price target raised to $915 from $860 at Wells Fargo
The FlyRegeneron price target raised to $915 from $860 at Wells Fargo
4d ago
REGN
Regeneron price target raised to $800 from $756 at Baird
The FlyRegeneron price target raised to $800 from $756 at Baird
4d ago
REGN
Regeneron price target raised to $915 from $815 at Barclays
The FlyRegeneron price target raised to $915 from $815 at Barclays
4d ago
REGN
Regeneron upgraded to Buy on COPD opportunity at Jefferies
The FlyRegeneron upgraded to Buy on COPD opportunity at Jefferies
4d ago
REGN
Regeneron upgraded to Buy from Hold at Jefferies
The FlyRegeneron upgraded to Buy from Hold at Jefferies
4d ago
REGN
Raymond James ups Regeneron to Market Perform as few downside catalysts remain
The FlyRaymond James ups Regeneron to Market Perform as few downside catalysts remain
5d ago
REGN
Regeneron upgraded to Market Perform from Underperform at Raymond James
The FlyRegeneron upgraded to Market Perform from Underperform at Raymond James
5d ago
REGN
Regeneron, Sanofi report Dupixent trial meets primary and secondary endpoints
The FlyRegeneron, Sanofi report Dupixent trial meets primary and secondary endpoints
5d ago
SNY
REGN
Dupixent® (dupilumab) Demonstrates Potential to Become First Biologic to Treat COPD by Showing Significant Reduction in Exacerbations in Pivotal Trial
Press ReleasesDupixent® (dupilumab) Demonstrates Potential to Become First Biologic to Treat COPD by Showing Significant Reduction in Exacerbations in Pivotal Trial
5d ago
REGN
Regeneron announces FDA approval of Evkeeza for young children
The FlyRegeneron announces FDA approval of Evkeeza for young children
6d ago
REGN
Regeneron, Sanofi announce EC approval of Dupixent
The FlyRegeneron, Sanofi announce EC approval of Dupixent
7d ago
SNY
REGN
Dupixent® (dupilumab) Approved by European Commission as First and Only Targeted Medicine for Children as Young as Six Months Old with Severe Atopic Dermatitis
Press ReleasesDupixent® (dupilumab) Approved by European Commission as First and Only Targeted Medicine for Children as Young as Six Months Old with Severe Atopic Dermatitis
7d ago
REGN
Regeneron price target lowered to $802 from $806 at RBC Capital
The FlyRegeneron price target lowered to $802 from $806 at RBC Capital
8d ago
REGN
Regeneron, Sanofi present results from Dupixent clinical trial
The FlyRegeneron, Sanofi present results from Dupixent clinical trial
9d ago
SNY
REGN
Dupixent® (dupilumab) Late-Breaking Data at AAD Show Significant Improvements in Signs and Symptoms of Moderate-to-severe Atopic Hand and Foot Dermatitis
Press ReleasesDupixent® (dupilumab) Late-Breaking Data at AAD Show Significant Improvements in Signs and Symptoms of Moderate-to-severe Atopic Hand and Foot Dermatitis
10d ago
REGN
Regeneron pressure from CMS draft a buying opportunity, says Morgan Stanley
The FlyRegeneron pressure from CMS draft a buying opportunity, says Morgan Stanley
11d ago
REGN
Students Win More Than $1.8 Million at 2023 Regeneron Science Talent Search for Remarkable Scientific Research on RNA Molecule Structure, Media Bias, and Diagnostics for Pediatric Heart Disease
Press ReleasesStudents Win More Than $1.8 Million at 2023 Regeneron Science Talent Search for Remarkable Scientific Research on RNA Molecule Structure, Media Bias, and Diagnostics for Pediatric Heart Disease
14d ago
REGN